Literature DB >> 623074

The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.

H J Hodgson, D P Jewell.   

Abstract

As there have been reports of differences in mean levels of serum immunoglobulins between patients with ulcerative colitis and Crohn's disease, serum IgG, IgA, and IgM were estimated in 158 patients with inflammatory bowel disease and the results correlated with the clinical features of the patients. Although a higher mean IgG level in ulcerative colitis compared to Crohn's disease was confirmed, no difference was found when the comparison was limited to patients with colonic Crohn's disease. Patients with either disease had higher mean IgM levels than controls, and the IgM levels were higher on treatment with corticosteroids and showed a tendency to rise in remission. IgG and IgM levels were also higher in both diseases if extraintestinal manifestations were present. It is concluded that if clinical features, particularly disease site, are taken into account, the overall immunoglobulin responses in these two diseases show no differences.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623074     DOI: 10.1007/bf01073186

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  24 in total

1.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

2.  Microbial flora of the upper small bowel in Crohn's disease.

Authors:  W L Beeken; R E Kanich
Journal:  Gastroenterology       Date:  1973-09       Impact factor: 22.682

3.  Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.

Authors:  S L Gorbach; L Nahas; A G Plaut; L Weinstein; J F Patterson; R Levitan
Journal:  Gastroenterology       Date:  1968-04       Impact factor: 22.682

4.  Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis.

Authors:  E Monteiro; J Fossey; M Shiner; B S Drasar; A C Allison
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

5.  A clinico-immunological study of ulcerative colitis and ulcerative proctitis.

Authors:  A H Smith; I W Macphee
Journal:  Gut       Date:  1971-01       Impact factor: 23.059

6.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

7.  IgG and albumin turnover in Crohn's disease.

Authors:  G Bendixen; S Jarnum; J Soltoft; H Westergaard; B Weeke; M Yssing
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

8.  The liver in Crohn's disease.

Authors:  A D Perrett; G Higgins; H H Johnston; G R Massarella; S C Truelove; R Wrigth
Journal:  Q J Med       Date:  1971-04

9.  A study of the immunologic aspects of chronic ulcerative colitis and transmural colitis.

Authors:  S D Deodhar; W M Michener; R G Farmer
Journal:  Am J Clin Pathol       Date:  1969-05       Impact factor: 2.493

10.  Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells.

Authors:  D W Watson; A Quigley; R J Bolt
Journal:  Gastroenterology       Date:  1966-12       Impact factor: 22.682

View more
  10 in total

1.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats.

Authors:  S Choudhary; A Keshavarzian; S Yong; M Wade; S Bocckino; B J Day; A Banan
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

5.  Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.

Authors:  M C Winslet; A Allan; V Poxon; D Youngs; M R Keighley
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

6.  Influence of nutritional status on immune functions in patients with Crohn's disease.

Authors:  A D Harries; V A Danis; R V Heatley
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

7.  Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients.

Authors:  J Goral; S Shenoy; T Mohanakumar; J Clancy
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

8.  Hyperthyroidism and ulcerative colitis: report of two cases and a review of the literature.

Authors:  S K Iyer; R G Karlstadt
Journal:  J Natl Med Assoc       Date:  1980-02       Impact factor: 1.798

9.  The effect of a selective 5-lipoxygenase inhibitor, zileuton, on tissue damage in acute colonic inflammation in rats.

Authors:  A Zarif; D Eiznhamer; C Callaghan; M I Doria; L Broutman; A Keshavarzian
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092

10.  Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease.

Authors:  Yanyan Wang; Chengyong Li; Weiyi Wang; Jiajia Wang; Jinhui Li; Shuangjie Qian; Chao Cai; Yuntao Liu
Journal:  J Inflamm Res       Date:  2022-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.